WELLCOME TRUST SANGER INSTITUTE WELLCOME TRUST
Forming part of the Wellcome To accommodate the expanded The Wellcome Trust was created
Trust Genome Campus at research programme at the Sanger on the death of Sir Henry
Hinxton in Cambridgeshire, Institute, the £95 million South Wellcome in 1936. In 1880, Henry
UK, the Wellcome Trust Sanger Field Project was completed in Wellcome and his partner Silas
Institute is one of the world’s 2005 – providing new laboratories, Mainville Burroughs established
foremost centres for genomics a data centre, research support a pharmaceutical company,
and bioinformatics research. facilities and offices. Burroughs Wellcome & Co.
Established in 1993, the Sanger In 1895, Silas Burroughs died,
In addition to the Sanger Institute,
Institute played a leading role leaving the company in the
the Genome Campus houses the
in the international Human hands of his partner. The firm
European Bioinformatics Institute
Genome Project – delivering flourished under Henry Wellcome’s
(EBI). The Wellcome Trust has
one-third of the human genome leadership. In his will, Wellcome
committed to work with the UK
sequence (the largest single vested the entire share capital of
Research Councils to create space
contribution). It has also the drug company, The Wellcome
for an expansion to this vital
sequenced the genomes of many Foundation Limited, in a charitable
research institute.
medically important pathogenic trust – the Wellcome Trust.
organisms – including the agents The Genome Campus is also
In the 1980s and 1990s, we
that cause malaria, tuberculosis home to the Wellcome Trust
diversified our asset base, selling
and typhoid fever. Conference Centre – a high-
shares in the Wellcome drug
quality venue for major
During the period of the Wellcome company and investing the
international scientific meetings
Trust’s last Plan, we funded a proceeds. The diversified portfolio
and conferences. Through its
£300 million five-year programme of investment assets is around
Advanced Courses programme,
of research at the Institute. Under £11 billion (as of June 2005).
the Wellcome Trust has utilised
the leadership of Allan Bradley,
the unique facilities available
the current Director, the focus
on the Genome Campus to
of the Institute has shifted from
provide hands-on training in
sequencing genomes to using
the latest research techniques
sequence data to answer important
for hundreds of scientists from
biological questions on the role
around the world.
of genes in health and disease.
INTRODUCTION STRATEGIC PLAN 2005–2010 5
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32